Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
McKesson
Medtronic
Express Scripts

Last Updated: May 26, 2022

BEVESPI AEROSPHERE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Bevespi Aerosphere patents expire, and what generic alternatives are available?

Bevespi Aerosphere is a drug marketed by Astrazeneca and is included in one NDA. There are seven patents protecting this drug.

This drug has one hundred and seventy-three patent family members in thirty-one countries.

The generic ingredient in BEVESPI AEROSPHERE is formoterol fumarate; glycopyrrolate. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the formoterol fumarate; glycopyrrolate profile page.

DrugPatentWatch® Generic Entry Outlook for Bevespi Aerosphere

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be May 28, 2030. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

  Sign up for a Free Trial

Summary for BEVESPI AEROSPHERE
Drug patent expirations by year for BEVESPI AEROSPHERE
Drug Prices for BEVESPI AEROSPHERE

See drug prices for BEVESPI AEROSPHERE

DrugPatentWatch® Estimated Generic Entry Opportunity Date for BEVESPI AEROSPHERE
Generic Entry Date for BEVESPI AEROSPHERE*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
AEROSOL, METERED;INHALATION

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for BEVESPI AEROSPHERE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bastiaan DriehuysPhase 2/Phase 3
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical CenterPhase 4
Los Angeles Biomedical Research InstitutePhase 4

See all BEVESPI AEROSPHERE clinical trials

US Patents and Regulatory Information for BEVESPI AEROSPHERE

BEVESPI AEROSPHERE is protected by seven US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of BEVESPI AEROSPHERE is See Plans and Pricing.

This potential generic entry date is based on patent See Plans and Pricing.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting BEVESPI AEROSPHERE

Compositions for pulmonary delivery of long-acting muscarinic antagonists or long-acting B2 adrenergic receptor agonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions for pulmonary delivery of long-acting .beta..sub.2 adrenergic receptor agonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions, methods and systems for respiratory delivery of two or more active agents
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: USE FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Astrazeneca BEVESPI AEROSPHERE formoterol fumarate; glycopyrrolate AEROSOL, METERED;INHALATION 208294-001 Apr 25, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for BEVESPI AEROSPHERE

When does loss-of-exclusivity occur for BEVESPI AEROSPHERE?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 6621
Estimated Expiration: See Plans and Pricing

Patent: 6806
Estimated Expiration: See Plans and Pricing

Patent: 6807
Estimated Expiration: See Plans and Pricing

Australia

Patent: 10253770
Estimated Expiration: See Plans and Pricing

Patent: 10253776
Estimated Expiration: See Plans and Pricing

Patent: 10253950
Estimated Expiration: See Plans and Pricing

Patent: 15201037
Estimated Expiration: See Plans and Pricing

Patent: 17201709
Estimated Expiration: See Plans and Pricing

Patent: 18282272
Estimated Expiration: See Plans and Pricing

Patent: 20210160
Estimated Expiration: See Plans and Pricing

Brazil

Patent: 1011220
Estimated Expiration: See Plans and Pricing

Patent: 1011229
Estimated Expiration: See Plans and Pricing

Patent: 1011508
Estimated Expiration: See Plans and Pricing

Canada

Patent: 63936
Estimated Expiration: See Plans and Pricing

Patent: 63939
Estimated Expiration: See Plans and Pricing

Patent: 63941
Estimated Expiration: See Plans and Pricing

China

Patent: 2458364
Estimated Expiration: See Plans and Pricing

Patent: 2596176
Estimated Expiration: See Plans and Pricing

Patent: 2753152
Estimated Expiration: See Plans and Pricing

Patent: 5193773
Estimated Expiration: See Plans and Pricing

Patent: 7412212
Estimated Expiration: See Plans and Pricing

Patent: 7669664
Estimated Expiration: See Plans and Pricing

Croatia

Patent: 0161098
Estimated Expiration: See Plans and Pricing

Patent: 0161101
Estimated Expiration: See Plans and Pricing

Patent: 0161102
Estimated Expiration: See Plans and Pricing

Patent: 0200166
Estimated Expiration: See Plans and Pricing

Patent: 0200260
Estimated Expiration: See Plans and Pricing

Patent: 0200298
Estimated Expiration: See Plans and Pricing

Cyprus

Patent: 18030
Estimated Expiration: See Plans and Pricing

Patent: 18034
Estimated Expiration: See Plans and Pricing

Patent: 18040
Estimated Expiration: See Plans and Pricing

Denmark

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

European Patent Office

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

Hong Kong

Patent: 69026
Estimated Expiration: See Plans and Pricing

Patent: 69027
Estimated Expiration: See Plans and Pricing

Patent: 69307
Estimated Expiration: See Plans and Pricing

Patent: 18867
Estimated Expiration: See Plans and Pricing

Patent: 44669
Estimated Expiration: See Plans and Pricing

Patent: 47095
Estimated Expiration: See Plans and Pricing

Hungary

Patent: 29532
Estimated Expiration: See Plans and Pricing

Patent: 31229
Estimated Expiration: See Plans and Pricing

Patent: 31283
Estimated Expiration: See Plans and Pricing

Patent: 47803
Estimated Expiration: See Plans and Pricing

Patent: 47823
Estimated Expiration: See Plans and Pricing

Patent: 47834
Estimated Expiration: See Plans and Pricing

Patent: 900031
Estimated Expiration: See Plans and Pricing

Patent: 100018
Estimated Expiration: See Plans and Pricing

Israel

Patent: 6466
Estimated Expiration: See Plans and Pricing

Patent: 6467
Estimated Expiration: See Plans and Pricing

Patent: 6468
Estimated Expiration: See Plans and Pricing

Japan

Patent: 23383
Estimated Expiration: See Plans and Pricing

Patent: 73012
Estimated Expiration: See Plans and Pricing

Patent: 73013
Estimated Expiration: See Plans and Pricing

Patent: 69639
Estimated Expiration: See Plans and Pricing

Patent: 89356
Estimated Expiration: See Plans and Pricing

Patent: 48645
Estimated Expiration: See Plans and Pricing

Patent: 92124
Estimated Expiration: See Plans and Pricing

Patent: 76734
Estimated Expiration: See Plans and Pricing

Patent: 12528199
Estimated Expiration: See Plans and Pricing

Patent: 12528200
Estimated Expiration: See Plans and Pricing

Patent: 12528792
Estimated Expiration: See Plans and Pricing

Patent: 15187108
Estimated Expiration: See Plans and Pricing

Patent: 15199735
Estimated Expiration: See Plans and Pricing

Patent: 16041713
Estimated Expiration: See Plans and Pricing

Patent: 17222706
Estimated Expiration: See Plans and Pricing

Patent: 18008942
Estimated Expiration: See Plans and Pricing

Patent: 18048150
Estimated Expiration: See Plans and Pricing

Patent: 19108369
Estimated Expiration: See Plans and Pricing

Lithuania

Patent: 435025
Estimated Expiration: See Plans and Pricing

Patent: 2019014
Estimated Expiration: See Plans and Pricing

Patent: 2021511
Estimated Expiration: See Plans and Pricing

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

Luxembourg

Patent: 0124
Estimated Expiration: See Plans and Pricing

Mexico

Patent: 7126
Estimated Expiration: See Plans and Pricing

Patent: 0163
Estimated Expiration: See Plans and Pricing

Patent: 0164
Estimated Expiration: See Plans and Pricing

Patent: 11012684
Estimated Expiration: See Plans and Pricing

Patent: 11012685
Estimated Expiration: See Plans and Pricing

Patent: 11012783
Estimated Expiration: See Plans and Pricing

Montenegro

Patent: 631
Estimated Expiration: See Plans and Pricing

Netherlands

Patent: 0995
Estimated Expiration: See Plans and Pricing

Norway

Patent: 19026
Estimated Expiration: See Plans and Pricing

Patent: 21019
Estimated Expiration: See Plans and Pricing

Philippines

Patent: 017500778
Estimated Expiration: See Plans and Pricing

Poland

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

Portugal

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

Russian Federation

Patent: 80315
Estimated Expiration: See Plans and Pricing

Patent: 86297
Estimated Expiration: See Plans and Pricing

Patent: 13404
Estimated Expiration: See Plans and Pricing

Patent: 51771
Estimated Expiration: See Plans and Pricing

Patent: 11152960
Estimated Expiration: See Plans and Pricing

Patent: 11154083
Estimated Expiration: See Plans and Pricing

Patent: 11154148
Estimated Expiration: See Plans and Pricing

Patent: 15151358
Estimated Expiration: See Plans and Pricing

Patent: 16107464
Estimated Expiration: See Plans and Pricing

Patent: 16117972
Estimated Expiration: See Plans and Pricing

Patent: 20102859
Estimated Expiration: See Plans and Pricing

San Marino

Patent: 01600326
Estimated Expiration: See Plans and Pricing

Patent: 01600327
Estimated Expiration: See Plans and Pricing

Patent: 01600329
Estimated Expiration: See Plans and Pricing

Slovenia

Patent: 35023
Estimated Expiration: See Plans and Pricing

Patent: 35024
Estimated Expiration: See Plans and Pricing

Patent: 35025
Estimated Expiration: See Plans and Pricing

Patent: 06149
Estimated Expiration: See Plans and Pricing

Patent: 11926
Estimated Expiration: See Plans and Pricing

Patent: 11927
Estimated Expiration: See Plans and Pricing

South Africa

Patent: 1208100
Estimated Expiration: See Plans and Pricing

Patent: 1208101
Estimated Expiration: See Plans and Pricing

Patent: 1208102
Estimated Expiration: See Plans and Pricing

South Korea

Patent: 1748892
Estimated Expiration: See Plans and Pricing

Patent: 1926060
Estimated Expiration: See Plans and Pricing

Patent: 1976107
Estimated Expiration: See Plans and Pricing

Patent: 120015334
Estimated Expiration: See Plans and Pricing

Patent: 120026075
Estimated Expiration: See Plans and Pricing

Patent: 120034631
Estimated Expiration: See Plans and Pricing

Patent: 170070274
Estimated Expiration: See Plans and Pricing

Patent: 170104003
Estimated Expiration: See Plans and Pricing

Patent: 180130602
Estimated Expiration: See Plans and Pricing

Patent: 190049943
Estimated Expiration: See Plans and Pricing

Spain

Patent: 89135
Estimated Expiration: See Plans and Pricing

Patent: 92536
Estimated Expiration: See Plans and Pricing

Patent: 93429
Estimated Expiration: See Plans and Pricing

Patent: 72253
Estimated Expiration: See Plans and Pricing

Patent: 74367
Estimated Expiration: See Plans and Pricing

Patent: 74391
Estimated Expiration: See Plans and Pricing

Taiwan

Patent: 39979
Estimated Expiration: See Plans and Pricing

Patent: 46094
Estimated Expiration: See Plans and Pricing

Patent: 32926
Estimated Expiration: See Plans and Pricing

Patent: 33898
Estimated Expiration: See Plans and Pricing

Patent: 46980
Estimated Expiration: See Plans and Pricing

Patent: 95723
Estimated Expiration: See Plans and Pricing

Patent: 07700
Estimated Expiration: See Plans and Pricing

Patent: 17511
Estimated Expiration: See Plans and Pricing

Patent: 1109049
Estimated Expiration: See Plans and Pricing

Patent: 1109050
Estimated Expiration: See Plans and Pricing

Patent: 1109051
Estimated Expiration: See Plans and Pricing

Patent: 1642836
Estimated Expiration: See Plans and Pricing

Patent: 1700123
Estimated Expiration: See Plans and Pricing

Patent: 1808372
Estimated Expiration: See Plans and Pricing

Patent: 1919730
Estimated Expiration: See Plans and Pricing

Patent: 1936174
Estimated Expiration: See Plans and Pricing

Patent: 2114642
Estimated Expiration: See Plans and Pricing

Ukraine

Patent: 9529
Estimated Expiration: See Plans and Pricing

Patent: 9530
Estimated Expiration: See Plans and Pricing

Patent: 9531
Estimated Expiration: See Plans and Pricing

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering BEVESPI AEROSPHERE around the world.

Country Patent Number Title Estimated Expiration
Canada 2763939 COMPOSITIONS PERMETTANT L'ADMINISTRATION PAR VOIE PULMONAIRE D'ANTAGONISTES, A ACTION PROLONGEE, DES RECEPTEURS MUSCARINIQUES ET D'AGONISTES, A ACTION PROLONGEE, DES RECEPTEURS ADRENERGIQUES B2 ET METHODES ET SYSTEMES ASSOCIES (COMPOSITIONS FOR PULMONARY DELIVERY OF LONG-ACTING MUSCARINIC ANTAGONISTS AND LONG-ACTING B2 ADRENERGIC RECEPTOR AGONISTS AND ASSOCIATED METHODS AND SYSTEMS) See Plans and Pricing
Taiwan 201109049 Compositions for respiratory delivery of active agents and associated methods and systems See Plans and Pricing
Australia 2020210160 COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS See Plans and Pricing
Australia 2010253770 Compositions for respiratory delivery of active agents and associated methods and systems See Plans and Pricing
Brazil PI1011229 co-suspensão, inalador de dose medida, e, métodos de preparação de um inalador de dose medida, de dispensação respiratória de um agente ativo a um paciente, e para tratar de um paciente. See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for BEVESPI AEROSPHERE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2435024 PA2021511 Lithuania See Plans and Pricing PRODUCT NAME: FORMOTEROLIO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS), GLIKOPIROLATO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENANTIOMERUS) IR BUDEZONIDO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, SOLVATUS ARBA ENATIOMERUS) DERINYS; REGISTRATION NO/DATE: EU/1/20/1498 20201209
2435024 21C1020 France See Plans and Pricing PRODUCT NAME: COMBINAISON DE FORMOTEROL (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI), GLYCOPYRROLATE (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI) ET BUDESONIDE (Y COMPRIS LES SELS, ESTERS, SOLVATES OU ENANTIOMERES PHARMACEUTIQUEMENT ACCEPTABLES DE CELUI-CI); REGISTRATION NO/DATE: EU/1/20/1498 20201210
2435025 PA2019014 Lithuania See Plans and Pricing PRODUCT NAME: GLIKOPIROLATO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, ENANTIOMERUS AR KITUS DARINIUS) IR FORMOTEROLIO (ISKAITANT BET KOKIAS JO FARMACINIU POZIURIU PRIIMTINAS DRUSKAS, ESTERIUS, ENANTIOMERUS AR KITUS DARINIUS) DERINYS; REGISTRATION NO/DATE: EU/1/18/1339 20181218
2435024 CA 2021 00014 Denmark See Plans and Pricing PRODUCT NAME: KOMBINATION AF FORMOTEROL, HERUNDER ALLE FARMACEUTISK ACCEPTABLE SALTE, ESTERE, SOLVATER ELLER ENANTIOMERE DERAF, GLYCOPYRROLAT, HERUNDER ALLE FARMACEUTISK ACCEPTABLE SALTE, ESTERE, SOLVATER ELLER ENANTIOMERE DERAF, OG BUDESONID, HERUNDER...; REG. NO/DATE: EU/1/20/1498 20201210
2435024 301102 Netherlands See Plans and Pricing PRODUCT NAME: COMBINATIE VAN FORMOTEROL (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN), GLYCOPYRROLAAT (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN) EN BUDESONIDE (MET INBEGRIP VAN DE FARMACEUTISCH AANVAARDBARE ZOUTEN, ESTERS, SOLVATEN OF ENANTIOMEREN ERVAN); REGISTRATION NO/DATE: EU/1/20/1498 20201210
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKesson
Medtronic
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.